Table 1.

The table describes the location of C. krusei isolation in patients with either confirmed invasive infection, patients with potentially significant infection, or patients with C. krusei colonization.

Patient	sex, age	Diagnosis	C. krusei isolation
1	F 32	AML	BSI
2	M 62	AML	BSI
3	M 71	duodenal carcinoma	BSI
4	F 46	mastocytosis	BSI
5	F 64	abdominal surgery	BSI
6	M 86	CLL	BSI
7	M 53	AML	peritoneum
8	M 22	ALL	peritoneum
9	M 33	AML	oesophagus
10	M 39	AML	kidney, liver
11	F 53	AML	invasive candidiasis in autopsy
12	M 55	AML	invasive candidiasis in autopsy
13	F 62	AML	typhlitis, pneumonia
14	M 67	AML	aortitis, pneumonia
15	M 69	multiple myeloma	severe mucositis
16	F 59	AML	rectum, pharynx
17	F 66	MDS	rectum, pharynx
18	F 59	lymphoma	rectum, pharynx
19	F 70	MDS	rectum, pharynx
20	M 22	toxic reaction*	rectum, pharynx
21	M 21	eosinophilic leukaemia	rectum, pharynx
22	M 65	AML	rectum, pharynx

M, male; F, female; BSI, blood stream infection; AML, acute myeloid leukaemia; ALL, acute lymphatic leukaemia; CLL, chronic lymphatic leukaemia; MDS, myelodysplastic syndrome.

*The toxic reaction refers to bone marrow suppression due to alcohol abuse